NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Weak Patents Are a Weak Deterrent: Patent Portfolios, the Orange Book Listing Standard, and Generic Entry in Pharmaceuticals

C. Scott Hemphill, Bhaven N. Sampat

Chapter in NBER book Standards, Patents and Innovations (2014), Timothy Simcoe, Ajay K. Agrawal, and Stuart Graham, organizers
Conference held January 20-21, 2012
Published in September 2014 by International Journal of Industrial Organization, Volume 36

This chapter is not currently available on-line.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Users who downloaded this chapter also downloaded* these:
Anton, Greene, and Yao Policy Implications of Weak Patent Rights
Mansfield R&D and Innovation: Some Empirical Findings
Oi The Welfare Implications of Invention
Danzon and Keuffel Regulation of the Pharmaceutical-Biotechnology Industry
Berndt, Kyle, and Ling The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us